IDSA: vaccinul matern RSVpreF ar reduce costurile clinice și financiare.

Published Date: 18 Oct 2023

The clinical and monetary burden of RSV lower respiratory tract illness (LRTI) is anticipated to decrease with maternal vaccination against the respiratory syncytial virus (RSV) using a bivalent stabilized prefusion F subunit vaccine (RSVpreF).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

2.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

3.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

4.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

5.

CDC Alerts on Dramatic Rise in Human Parvovirus B19


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot